- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Gene Therapy market size is estimated to be worth US$ 7282.5 million in 2021 and is forecast to a readjusted size of USD 37570 million by 2028 with a CAGR of 26.4% during review period. Neurological Diseases accounting for % of the Gene Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Viral Gene Therapy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Gene Therapy include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, and Alnylam Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gene Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Viral Gene Therapy
Non-Viral Gene Therapy
Market segment by Application, can be divided into
Neurological Diseases
Cancer
Other
Market segment by players, this report covers
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gene Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gene Therapy, with revenue, gross margin and global market share of Gene Therapy from 2019 to 2022.
Chapter 3, the Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Gene Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Gene Therapy research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Gene Therapy
1.2 Classification of Gene Therapy by Type
1.2.1 Overview: Global Gene Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Gene Therapy Revenue Market Share by Type in 2021
1.2.3 Viral Gene Therapy
1.2.4 Non-Viral Gene Therapy
1.3 Global Gene Therapy Market by Application
1.3.1 Overview: Global Gene Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Global Gene Therapy Market Size & Forecast
1.5 Global Gene Therapy Market Size and Forecast by Region
1.5.1 Global Gene Therapy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Gene Therapy Market Size by Region, (2017-2022)
1.5.3 North America Gene Therapy Market Size and Prospect (2017-2028)
1.5.4 Europe Gene Therapy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Gene Therapy Market Size and Prospect (2017-2028)
1.5.6 South America Gene Therapy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Gene Therapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene Therapy Market Drivers
1.6.2 Gene Therapy Market Restraints
1.6.3 Gene Therapy Trends Analysis
2 Company Profiles
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business
2.1.3 Biogen Gene Therapy Product and Solutions
2.1.4 Biogen Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Biogen Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Gene Therapy Product and Solutions
2.2.4 Novartis Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Gilead Sciences
2.3.1 Gilead Sciences Details
2.3.2 Gilead Sciences Major Business
2.3.3 Gilead Sciences Gene Therapy Product and Solutions
2.3.4 Gilead Sciences Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Gilead Sciences Recent Developments and Future Plans
2.4 Sarepta Therapeutics
2.4.1 Sarepta Therapeutics Details
2.4.2 Sarepta Therapeutics Major Business
2.4.3 Sarepta Therapeutics Gene Therapy Product and Solutions
2.4.4 Sarepta Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
2.5 Alnylam Pharmaceuticals
2.5.1 Alnylam Pharmaceuticals Details
2.5.2 Alnylam Pharmaceuticals Major Business
2.5.3 Alnylam Pharmaceuticals Gene Therapy Product and Solutions
2.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Gene Therapy Product and Solutions
2.6.4 Amgen Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Spark Therapeutics
2.7.1 Spark Therapeutics Details
2.7.2 Spark Therapeutics Major Business
2.7.3 Spark Therapeutics Gene Therapy Product and Solutions
2.7.4 Spark Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Spark Therapeutics Recent Developments and Future Plans
2.8 Akcea Therapeutics
2.8.1 Akcea Therapeutics Details
2.8.2 Akcea Therapeutics Major Business
2.8.3 Akcea Therapeutics Gene Therapy Product and Solutions
2.8.4 Akcea Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Akcea Therapeutics Recent Developments and Future Plans
2.9 bluebird bio
2.9.1 bluebird bio Details
2.9.2 bluebird bio Major Business
2.9.3 bluebird bio Gene Therapy Product and Solutions
2.9.4 bluebird bio Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 bluebird bio Recent Developments and Future Plans
2.10 Sunway Biotech
2.10.1 Sunway Biotech Details
2.10.2 Sunway Biotech Major Business
2.10.3 Sunway Biotech Gene Therapy Product and Solutions
2.10.4 Sunway Biotech Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Sunway Biotech Recent Developments and Future Plans
2.11 SIBIONO
2.11.1 SIBIONO Details
2.11.2 SIBIONO Major Business
2.11.3 SIBIONO Gene Therapy Product and Solutions
2.11.4 SIBIONO Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 SIBIONO Recent Developments and Future Plans
2.12 AnGes
2.12.1 AnGes Details
2.12.2 AnGes Major Business
2.12.3 AnGes Gene Therapy Product and Solutions
2.12.4 AnGes Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 AnGes Recent Developments and Future Plans
2.13 Orchard Therapeutics
2.13.1 Orchard Therapeutics Details
2.13.2 Orchard Therapeutics Major Business
2.13.3 Orchard Therapeutics Gene Therapy Product and Solutions
2.13.4 Orchard Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Orchard Therapeutics Recent Developments and Future Plans
2.14 Human Stem Cells Institute
2.14.1 Human Stem Cells Institute Details
2.14.2 Human Stem Cells Institute Major Business
2.14.3 Human Stem Cells Institute Gene Therapy Product and Solutions
2.14.4 Human Stem Cells Institute Gene Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Human Stem Cells Institute Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gene Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Gene Therapy Players Market Share in 2021
3.2.2 Top 10 Gene Therapy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Gene Therapy Players Head Office, Products and Services Provided
3.4 Gene Therapy Mergers & Acquisitions
3.5 Gene Therapy New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gene Therapy Revenue and Market Share by Type (2017-2022)
4.2 Global Gene Therapy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Gene Therapy Revenue Market Share by Application (2017-2022)
5.2 Global Gene Therapy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Gene Therapy Revenue by Type (2017-2028)
6.2 North America Gene Therapy Revenue by Application (2017-2028)
6.3 North America Gene Therapy Market Size by Country
6.3.1 North America Gene Therapy Revenue by Country (2017-2028)
6.3.2 United States Gene Therapy Market Size and Forecast (2017-2028)
6.3.3 Canada Gene Therapy Market Size and Forecast (2017-2028)
6.3.4 Mexico Gene Therapy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Gene Therapy Revenue by Type (2017-2028)
7.2 Europe Gene Therapy Revenue by Application (2017-2028)
7.3 Europe Gene Therapy Market Size by Country
7.3.1 Europe Gene Therapy Revenue by Country (2017-2028)
7.3.2 Germany Gene Therapy Market Size and Forecast (2017-2028)
7.3.3 France Gene Therapy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Gene Therapy Market Size and Forecast (2017-2028)
7.3.5 Russia Gene Therapy Market Size and Forecast (2017-2028)
7.3.6 Italy Gene Therapy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gene Therapy Revenue by Type (2017-2028)
8.2 Asia-Pacific Gene Therapy Revenue by Application (2017-2028)
8.3 Asia-Pacific Gene Therapy Market Size by Region
8.3.1 Asia-Pacific Gene Therapy Revenue by Region (2017-2028)
8.3.2 China Gene Therapy Market Size and Forecast (2017-2028)
8.3.3 Japan Gene Therapy Market Size and Forecast (2017-2028)
8.3.4 South Korea Gene Therapy Market Size and Forecast (2017-2028)
8.3.5 India Gene Therapy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Gene Therapy Market Size and Forecast (2017-2028)
8.3.7 Australia Gene Therapy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Gene Therapy Revenue by Type (2017-2028)
9.2 South America Gene Therapy Revenue by Application (2017-2028)
9.3 South America Gene Therapy Market Size by Country
9.3.1 South America Gene Therapy Revenue by Country (2017-2028)
9.3.2 Brazil Gene Therapy Market Size and Forecast (2017-2028)
9.3.3 Argentina Gene Therapy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gene Therapy Revenue by Type (2017-2028)
10.2 Middle East & Africa Gene Therapy Revenue by Application (2017-2028)
10.3 Middle East & Africa Gene Therapy Market Size by Country
10.3.1 Middle East & Africa Gene Therapy Revenue by Country (2017-2028)
10.3.2 Turkey Gene Therapy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Gene Therapy Market Size and Forecast (2017-2028)
10.3.4 UAE Gene Therapy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Gene Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Gene Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Gene Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Gene Therapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Gene Therapy Revenue Market Share by Region (2023-2028)
Table 6. Biogen Corporate Information, Head Office, and Major Competitors
Table 7. Biogen Major Business
Table 8. Biogen Gene Therapy Product and Solutions
Table 9. Biogen Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Gene Therapy Product and Solutions
Table 13. Novartis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 15. Gilead Sciences Major Business
Table 16. Gilead Sciences Gene Therapy Product and Solutions
Table 17. Gilead Sciences Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Sarepta Therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. Sarepta Therapeutics Major Business
Table 20. Sarepta Therapeutics Gene Therapy Product and Solutions
Table 21. Sarepta Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Alnylam Pharmaceuticals Major Business
Table 24. Alnylam Pharmaceuticals Gene Therapy Product and Solutions
Table 25. Alnylam Pharmaceuticals Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Amgen Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Major Business
Table 28. Amgen Gene Therapy Product and Solutions
Table 29. Amgen Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Spark Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Spark Therapeutics Major Business
Table 32. Spark Therapeutics Gene Therapy Product and Solutions
Table 33. Spark Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Akcea Therapeutics Corporate Information, Head Office, and Major Competitors
Table 35. Akcea Therapeutics Major Business
Table 36. Akcea Therapeutics Gene Therapy Product and Solutions
Table 37. Akcea Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. bluebird bio Corporate Information, Head Office, and Major Competitors
Table 39. bluebird bio Major Business
Table 40. bluebird bio Gene Therapy Product and Solutions
Table 41. bluebird bio Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sunway Biotech Corporate Information, Head Office, and Major Competitors
Table 43. Sunway Biotech Major Business
Table 44. Sunway Biotech Gene Therapy Product and Solutions
Table 45. Sunway Biotech Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. SIBIONO Corporate Information, Head Office, and Major Competitors
Table 47. SIBIONO Major Business
Table 48. SIBIONO Gene Therapy Product and Solutions
Table 49. SIBIONO Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. AnGes Corporate Information, Head Office, and Major Competitors
Table 51. AnGes Major Business
Table 52. AnGes Gene Therapy Product and Solutions
Table 53. AnGes Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Orchard Therapeutics Corporate Information, Head Office, and Major Competitors
Table 55. Orchard Therapeutics Major Business
Table 56. Orchard Therapeutics Gene Therapy Product and Solutions
Table 57. Orchard Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Human Stem Cells Institute Corporate Information, Head Office, and Major Competitors
Table 59. Human Stem Cells Institute Major Business
Table 60. Human Stem Cells Institute Gene Therapy Product and Solutions
Table 61. Human Stem Cells Institute Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Gene Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Gene Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Gene Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Gene Therapy Players Head Office, Products and Services Provided
Table 66. Gene Therapy Mergers & Acquisitions in the Past Five Years
Table 67. Gene Therapy New Entrants and Expansion Plans
Table 68. Global Gene Therapy Revenue (USD Million) by Type (2017-2022)
Table 69. Global Gene Therapy Revenue Share by Type (2017-2022)
Table 70. Global Gene Therapy Revenue Forecast by Type (2023-2028)
Table 71. Global Gene Therapy Revenue by Application (2017-2022)
Table 72. Global Gene Therapy Revenue Forecast by Application (2023-2028)
Table 73. North America Gene Therapy Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Gene Therapy Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Gene Therapy Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Gene Therapy Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Gene Therapy Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Gene Therapy Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Gene Therapy Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Gene Therapy Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Gene Therapy Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Gene Therapy Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Gene Therapy Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Gene Therapy Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Gene Therapy Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Gene Therapy Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Gene Therapy Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Gene Therapy Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Gene Therapy Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Gene Therapy Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Gene Therapy Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Gene Therapy Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Gene Therapy Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Gene Therapy Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Gene Therapy Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Gene Therapy Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Gene Therapy Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Gene Therapy Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Gene Therapy Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Gene Therapy Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Gene Therapy Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Gene Therapy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Gene Therapy Picture
Figure 2. Global Gene Therapy Revenue Market Share by Type in 2021
Figure 3. Viral Gene Therapy
Figure 4. Non-Viral Gene Therapy
Figure 5. Gene Therapy Revenue Market Share by Application in 2021
Figure 6. Neurological Diseases Picture
Figure 7. Cancer Picture
Figure 8. Other Picture
Figure 9. Global Gene Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Gene Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Gene Therapy Revenue Market Share by Region (2017-2028)
Figure 12. Global Gene Therapy Revenue Market Share by Region in 2021
Figure 13. North America Gene Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Gene Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Gene Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Gene Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Gene Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Gene Therapy Market Drivers
Figure 19. Gene Therapy Market Restraints
Figure 20. Gene Therapy Market Trends
Figure 21. Biogen Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Gilead Sciences Recent Developments and Future Plans
Figure 24. Sarepta Therapeutics Recent Developments and Future Plans
Figure 25. Alnylam Pharmaceuticals Recent Developments and Future Plans
Figure 26. Amgen Recent Developments and Future Plans
Figure 27. Spark Therapeutics Recent Developments and Future Plans
Figure 28. Akcea Therapeutics Recent Developments and Future Plans
Figure 29. bluebird bio Recent Developments and Future Plans
Figure 30. Sunway Biotech Recent Developments and Future Plans
Figure 31. SIBIONO Recent Developments and Future Plans
Figure 32. AnGes Recent Developments and Future Plans
Figure 33. Orchard Therapeutics Recent Developments and Future Plans
Figure 34. Human Stem Cells Institute Recent Developments and Future Plans
Figure 35. Global Gene Therapy Revenue Share by Players in 2021
Figure 36. Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Gene Therapy Revenue Market Share in 2021
Figure 38. Global Top 10 Players Gene Therapy Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Gene Therapy Revenue Share by Type in 2021
Figure 41. Global Gene Therapy Market Share Forecast by Type (2023-2028)
Figure 42. Global Gene Therapy Revenue Share by Application in 2021
Figure 43. Global Gene Therapy Market Share Forecast by Application (2023-2028)
Figure 44. North America Gene Therapy Sales Market Share by Type (2017-2028)
Figure 45. North America Gene Therapy Sales Market Share by Application (2017-2028)
Figure 46. North America Gene Therapy Revenue Market Share by Country (2017-2028)
Figure 47. United States Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Gene Therapy Sales Market Share by Type (2017-2028)
Figure 51. Europe Gene Therapy Sales Market Share by Application (2017-2028)
Figure 52. Europe Gene Therapy Revenue Market Share by Country (2017-2028)
Figure 53. Germany Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Gene Therapy Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Gene Therapy Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Gene Therapy Revenue Market Share by Region (2017-2028)
Figure 61. China Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Gene Therapy Sales Market Share by Type (2017-2028)
Figure 68. South America Gene Therapy Sales Market Share by Application (2017-2028)
Figure 69. South America Gene Therapy Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Gene Therapy Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Gene Therapy Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Gene Therapy Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
